What is TG Therapeutics's change in inventories?

TG Therapeutics (TGTX) reported change in inventories of $13.28M in Q1 2026.

How has TG Therapeutics's change in inventories changed year-over-year?

TG Therapeutics's change in inventories decreased by 71.3% year-over-year, from $46.31M to $13.28M.

What does change in inventories mean?

Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.

TG Therapeutics TGTX Change in Inventories

Change in Inventories at other companies

BiogenBIIB

-$116.2M-87.4%

BridgeBio PharmaBBIO

$7.05M+121%

Krystal Biotech, Inc.KRYS

$243K-82.6%

LQD

Liquidia CorporationLQDA

$4.57M+312%

Rhythm Pharmaceuticals, Inc.RYTM

$3.09M+437%

Mirum Pharmaceuticals, Inc.MIRM

$1.92M-28.1%

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's change in inventories?: TG Therapeutics (TGTX) reported change in inventories of $13.28M in Q1 2026.
How has TG Therapeutics's change in inventories changed year-over-year?: TG Therapeutics's change in inventories decreased by 71.3% year-over-year, from $46.31M to $13.28M.
What does change in inventories mean?: Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.